Related Experiment Video

Updated: Jul 17, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Targeting metastatic prostate cancer: the search for innovative systemic therapies

Dominik R Berthold1, Malcolm J Moore

  • 1Department of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto Toronto, Ontario, Canada. dominik.berthold@uhn.on.ca

Oncology (Williston Park, N.Y.)
|February 1, 2007
PubMed

Insights

Metastatic hormone-resistant prostate cancer remains challenging to treat. This article reviews innovative targeted therapies for advanced prostate cancer, aiming to improve patient outcomes beyond current standards.

Area of Science:

  • Oncology
  • Cancer Research
  • Pharmacology

Background:

  • Metastatic hormone-resistant prostate cancer (mHRC) shows limited response to traditional cytotoxic chemotherapy.
  • Docetaxel/prednisone is the current standard, but offers modest survival benefits and non-response in many patients.
  • Understanding mHRC progression mechanisms is crucial for developing novel treatments.

Purpose of the Study:

  • To provide an overview of targeted and innovative therapeutic strategies for prostate cancer.
  • To discuss emerging treatments beyond conventional chemotherapy.
  • To highlight the growing potential of biologic and targeted agents in prostate cancer care.

Main Methods:

  • Literature review of targeted and innovative therapies for prostate cancer.
  • Analysis of current treatment standards and their limitations.
  • Exploration of novel therapeutic agents and their development status.

Main Results:

  • Current novel therapies have not yet surpassed the efficacy of standard treatments.
  • A growing pipeline of biologic and targeted agents is under development for prostate cancer.
  • Increased understanding of prostate cancer progression fuels the development of new treatment modalities.

Conclusions:

  • Targeted and innovative therapies offer promise for advanced prostate cancer.
  • Further research is needed to establish the superiority of new treatments over current standards.
  • The evolving landscape of prostate cancer treatment includes a focus on personalized and targeted approaches.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.